Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...
While both are called medullary carcinoma, these cancers differ in many ways: ...
13h
GlobalData on MSNAnocca gains European authorisation for Phase I/II trial of pancreatic cancer drugThe trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Pancreatic cancer’s deadly resilience may be tied to extrachromosomal DNA, which allows tumor cells to rapidly adapt to ...
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...
12h
Fintel on MSNLeerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform RecommendationFintel reports that on March 17, 2025, Leerink Partners initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...
CRISPR libraries enable scientists to systematically investigate gene functions, identify novel drug targets, and develop personalized therapies.
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection ...
DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an inhibitor of the ...
Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...
The Lung Cancer Genetics Project brings together the genetic testing company with UK-based patient advocacy and research group Oncogene Cancer Research, along with 20 other lung cancer charities ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström MacroglobulinemiaFirst-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results